Edwards Lifesciences Corp
(BSP:E1WL34)
R$
89.82
0.9 (1.01%)
Market Cap: 54.11 Bil
Enterprise Value: 47.34 Bil
PE Ratio: 26.95
PB Ratio: 5.30
GF Score: 88/100 Edwards Lifesciences Corp at Citi Healthcare Services, Medtech, Tools, & HCIT Virtual Conference Transcript
Feb 24, 2021 / 02:50PM GMT
Release Date Price:
R$116
(-0.68%)
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD
Well, everybody, welcome to our first meeting in the 2021 Citi Healthcare Virtual conference room. We're going to start this morning with Edwards Lifesciences and thrilled to have Scott Ullem with us. For those of you who don't know him, he is the CFO of Edwards. And Scott and I were just talking before this got started, how -- the whole new world that we are in here, this would be so much more fun if it was live. So Scott, welcome.
Scott B. Ullem
Edwards Lifesciences Corporation - Corporate VP & CFO
Yes. Thanks a lot, Joanne. Well, at least we could do it in this format instead of no format at all, and thanks, everyone, for joining, and we appreciate your interest in Edwards Lifesciences.
Questions & Answers
Joanne Karen Wuensch;Scott B. Ullem
Citigroup Inc., Research Division - MD;Edwards Lifesciences Corporation - Corporate VP
Now just trying to remember, Scott, how many years have you been at Edwards?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot